Skin Grafts for Gene Therapy Could Treat Type II Diabetes and Obesity
Scientists at the University of Chicago genetically modified skin cells to produce glucagon-like peptide 1 (GLP1) protein that is beneficial in diabetes and reduces appetite, and these investigators grew the cells in a dish to form a skin graft. The ...
Source: Medgadget - Category: Medical Devices Authors: Conn Hastings Tags: Genetics Medicine News Source Type: blogs
More News: Burns | Diabetes | Diets | Doxycycline | Eating Disorders & Weight Management | Endocrinology | Gene Therapy | Genetics | Haemophilia | Hemophilia | High Fat | Hormones | Insulin | Laboratory Medicine | Medical Devices | Nutrition | Obesity | Pancreas | Skin | Skin Graft | Stem Cell Therapy | Stem Cells | Study